We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

June 12, 2020

News You need - 3 Big Little Things

Commentary
Kate O'Reilly
&


Health economics outcomes evaluation; the new visitor to DTx

Read the story here.

Snapshot of the story

We need more cost effectiveness data as a collective to strengthen the case for health tech. Sleepio, a digital therapeutic that helps people with poor sleep, recently released its health economic outcomes assessment. The study was conducted at a self-insured Fortune 500 company, in collaboration with IBM Watson Health, and health economic consultant Dr. Laurence Baker.

Why this is notable:

Industry Implications:

Jane Sarasohn Kahn
Jane Sarasohn Kahn
Health Economist/Advisor, THINK-Health; Blogs at HealthPopuli
THINK-Health

Jane is an experienced health economist, and healthcare consultant, at the healthcare-technology-people interface who partners with healthcare stakeholders on strategy, scenario planning, policy, and healthcare reform. Connect with Jane to get her perspective on how cost effectiveness data is strengthening the case for digital health.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Omada making major moves on the investments stage

Read the story here.

Snapshot of the story

Omada Health recently raised a $57 million round of growth capital from the life sciences investment firm Perceptive Advisors. Omada subsequently used $30 million of that fundraise to acquire the musculoskeletal solutions company Physera. 

Why this is notable:

Industry Implications:

Lisa Suennen
Lisa Suennen
Venture Capital Investor, Entrepreneur, Advisor, Board Member
Venture Valkyrie

Lisa is a leading venture capital investor, entrepreneur and advisor, focusing on the worlds of innovation, digital transformation and frontier technologies. Connect with Lisa to get her perspective on investment trends in digital health and how partnerships are broadening the solutions landscape.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Covid-19 is no opportunity for hasty research

Read the story here.

Snapshot of the story

Two of the worlds’ leading medical journals Lancet and NEJM, have expressed concern about the accuracy of a few studies that have been published, in haste, over recent months - these papers have been retracted since. We are all living in the fast track lane, trying to get ahead and without the barriers that delay research, regulation, and market entry for our healthcare products and services. While Covid-19 has been a major driver to accelerating market pathways and diminishing market-entry barriers, we must continue to proceed with caution. While the pandemic presents certain opportunities there is not a more important time to ensure that whatever is marketed and accessible to patients is evidence-informed, safe, ethical, etc.

Why this is notable:

Industry Implications:

Jean Ledger (UCL)
Jean Ledger (UCL)
Health researcher, lecturer

Jean is an established social scientist, health researcher and lecturer at UCL who is passionate about exploring healthcare innovation and quality improvements and how they can be supported by government, policy, professionals and industry. Connect with Jean to get her perspective on addressing healthcare and social problems through evidence-based solutions.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Primary Care - The Front Door for Virtual Care Delivery

26th January @ 10.30am EDT

Join us for this session on Primary Care - The Front Door for Virtual Care Delivery.

Featuring
John Mattison
John Mattison
CMIO , Arsenal Capital
Kristi Ebong
Kristi Ebong
SVP Corporate Strategy, Orbita
Featuring
John Mattison
John Mattison
CMIO , Arsenal Capital
Kristi Ebong
Kristi Ebong
SVP Corporate Strategy, Orbita
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Digital Biomarkers

27th January @ 11.00am EDT

Join us for the second running of our Digital Health Meeting focused on Digital Biomarkers. Apply quickly to avoid disappointment.

Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Aahuti Rai
Aahuti Rai
Chief Strategy & Growth Officer at Ampersand Health
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Aahuti Rai
Aahuti Rai
Chief Strategy & Growth Officer at Ampersand Health
HCP and Patient Engagement
HCP and Patient Engagement
HCP and Patient Engagement
HCP and Patient Engagement

Data analytics & AI – Driving a more personalised experience for Pharma customers

28 January @ 11.00am

Join us for this event, meet new people, share your thoughts with leaders and keep the connection strong through this time.

Featuring
Natasha Gray
Natasha Gray
VP, Head of Data & Analytics at ViiV Healthcare
Rosie Kime
Rosie Kime
Senior Director Strategy and Planning MCE at ViiV Healthcare
Featuring
Natasha Gray
Natasha Gray
VP, Head of Data & Analytics at ViiV Healthcare
Rosie Kime
Rosie Kime
Senior Director Strategy and Planning MCE at ViiV Healthcare
Clinical Trials Optimization
Clinical Trials Optimization
Clinical Trials Optimization
Clinical Trials Optimization

Trial enrollment via social media

1st February @ 10am EDT

Join us for our meeting focused on Trial enrollment via social media where we will bring up 10 thought leaders together. Meet new people, learn and enjoy.

Featuring
James Allocco
James Allocco
Chief Technology Officer at PRA Health Sciences
Nicole Baker
Nicole Baker
CEO, Biologit
Featuring
James Allocco
James Allocco
Chief Technology Officer at PRA Health Sciences
Nicole Baker
Nicole Baker
CEO, Biologit

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.